BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World J Hepatol 2017; 9(19): 850-856 [PMID: 28740596 DOI: 10.4254/wjh.v9.i19.850]
URL: https://www.wjgnet.com/1948-5182/full/v9/i19/850.htm
Number Citing Articles
Wei Liu, Xiwen Jiang, Yue Liu, Qingsong Ma. Bioinformatics Analysis of Quantitative PCR and Reverse Transcription PCR in Detecting HCV RNACurrent Bioinformatics 2019; 14(5): 400 doi: 10.2174/1574893613666180703103328
Jose Hernandez Roman, Mohammad S. Siddiqui. The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver diseaseEndocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.127
Zhengyi Wang, Yi Huang, Hans Nossent, Jonathan J Chan, Leon A Adams, John Joseph, Wendy Cheng, George Garas, Gerry MacQuillan, Gary P Jeffrey. Hepascore predicts liver outcomes and all‐cause mortality in long‐term methotrexate users: A retrospective cohort studyJGH Open 2020; 4(6): 1211 doi: 10.1002/jgh3.12430